Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
By purchasing from our website, customers confirm that they are qualified researchers, laboratories, or research institutions and fully understand the research-use-only designation associated with these products
Returned, Refused, or Undeliverable Packages Packages refused by the recipient, returned because of an incorrect or incomplete address, left unclaimed, rejected by customs, or otherwise made undeliverable for reasons outside BGX's control are not eligible for a refund except where required by law
Scientific References TripleHormone-Receptor Agonist Retatrutide for Obesity (Phase 2 Trial)
The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
doi:10.3390/ijms19071987 6
US$ 21.92
US$ 22.55
US$ 24.11
US$ 29.23
